Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Estimate Rate of the Women Who Have Gestational Diabetes (ERD2-DIGERD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02852980
Recruitment Status : Completed
First Posted : August 2, 2016
Last Update Posted : July 29, 2019
Sponsor:
Information provided by (Responsible Party):
Centre Hospitalier René Dubos

Brief Summary:
Retrospective study to estimate screening of the type 2 diabetes of women who had childbirth in the Hospital center Rene Dubos and having gestational diabetes.

Condition or disease Intervention/treatment
Diabetes, Gestational Other: gestational diabetes women

Detailed Description:
It is recognized that pregnant women who had gestational diabetes (DG) multiplied by 7 subsequent risk of developing type 2 diabetes and this during 25 years. There is at present no formal recommendation of the High Authority for Health (HAS) as an organization of a long term screening for those women. However the recommendations of CNGOF (French Council of Gynaecologists and Obstetricians) and SFD (French society of diabetes) recommend screening for type 2 diabetes after a gestational diabetes in the postnatal consultation. But today how many women views due to a gestational diabetes have realized their screening? It is likely that the rate of occurrence of type 2 diabetes after gestational diabetes is underestimated today. Otherwise it is possible that the occurrence of type 2 diabetes is associated with some risk factors such as high BMI, insulin therapy during pregnancy. Another interrogation is the role of the doctor to reduce the number of women who do not realize their screening at 3 months postpartum. Better awareness of the importance of long term monitoring would reduce the proportion of women who do not realize their screening.

Layout table for study information
Study Type : Observational
Actual Enrollment : 384 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Retrospective Study to Estimate Screening of the Type 2 Diabetes of Women Who Had Childbirth in the Hospital Center Rene Dubos and Having Gestational Diabetes
Study Start Date : July 2015
Actual Primary Completion Date : January 2017
Actual Study Completion Date : January 2017

Resource links provided by the National Library of Medicine


Group/Cohort Intervention/treatment
gestational diabetes women
Women who had childbirth in the Hospital center Rene Dubos and who had gestational diabetes.
Other: gestational diabetes women
No intervention.




Primary Outcome Measures :
  1. Glycemia realized after childbirth [ Time Frame: 3 months ]
    The investigators want to know the number of women who realized a Glycemia analysis.


Secondary Outcome Measures :
  1. Percentage of women who have pursued the dietary and hygiene rules [ Time Frame: 3 months ]
    Information about dietary and hygiene rules are collected on a questionnaire.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Women who had childbirth in the Hospital center Rene Dubos and having gestational diabetes.
Criteria

Inclusion Criteria:

  • Participants aged over 18 years
  • Participants who deliver between 01/01/2013 and 30/06/2015
  • Participants who have had a gestational diabetes
  • Participants who have been informed and have returned the questionary

Exclusion Criteria:

  • Participants who do not wishing to participate in the study

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02852980


Locations
Layout table for location information
France
Rene Dubos Hospital
Pontoise, Val d'Oise, France, 95303
Sponsors and Collaborators
Centre Hospitalier René Dubos
Investigators
Layout table for investigator information
Principal Investigator: Catherine CAMPINOS, PH Rene Dubos Hospital
Layout table for additonal information
Responsible Party: Centre Hospitalier René Dubos
ClinicalTrials.gov Identifier: NCT02852980    
Other Study ID Numbers: CHRD1114
First Posted: August 2, 2016    Key Record Dates
Last Update Posted: July 29, 2019
Last Verified: July 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Diabetes, Gestational
Diabetes Mellitus
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Pregnancy Complications